H Lambert

2.2k total citations
50 papers, 1.7k citations indexed

About

H Lambert is a scholar working on Reproductive Medicine, Surgery and Obstetrics and Gynecology. According to data from OpenAlex, H Lambert has authored 50 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Reproductive Medicine, 11 papers in Surgery and 11 papers in Obstetrics and Gynecology. Recurrent topics in H Lambert's work include Ovarian cancer diagnosis and treatment (19 papers), Endometrial and Cervical Cancer Treatments (9 papers) and Reproductive Biology and Fertility (5 papers). H Lambert is often cited by papers focused on Ovarian cancer diagnosis and treatment (19 papers), Endometrial and Cervical Cancer Treatments (9 papers) and Reproductive Biology and Fertility (5 papers). H Lambert collaborates with scholars based in United Kingdom, United States and Norway. H Lambert's co-authors include Ann E. Nelstrop, G.J.S. Rustin, Malgorzata Tuxen, Walter M. Gregory, W.J. Hoskins, Hugh Mitchell, V Hird, M F Brady, William P. McGuire and Gordon Rustin and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.

In The Last Decade

H Lambert

48 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H Lambert United Kingdom 19 930 575 491 473 359 50 1.7k
Nina Einhorn Sweden 22 1.1k 1.1× 449 0.8× 207 0.4× 359 0.8× 574 1.6× 56 1.9k
R. C. Knapp United States 10 1.6k 1.8× 574 1.0× 339 0.7× 389 0.8× 495 1.4× 17 2.4k
George J. Olt United States 16 902 1.0× 680 1.2× 328 0.7× 767 1.6× 941 2.6× 38 2.3k
Jaume Pahisa Spain 32 862 0.9× 723 1.3× 367 0.7× 754 1.6× 1.1k 3.1× 85 2.7k
Arjun Jeyarajah United Kingdom 19 1.1k 1.2× 428 0.7× 151 0.3× 385 0.8× 761 2.1× 43 1.8k
Svend Aage Engelholm Denmark 29 895 1.0× 1.0k 1.7× 652 1.3× 812 1.7× 548 1.5× 94 3.3k
G. Le Bouëdec France 19 407 0.4× 435 0.8× 190 0.4× 570 1.2× 420 1.2× 90 1.7k
K. Bertelsen Denmark 25 1.4k 1.5× 1.1k 1.9× 102 0.2× 849 1.8× 769 2.1× 70 2.3k
JA Ledermann United Kingdom 24 407 0.4× 764 1.3× 311 0.6× 904 1.9× 90 0.3× 69 2.0k
Alexander W. Miller United States 21 907 1.0× 579 1.0× 75 0.2× 290 0.6× 668 1.9× 33 1.7k

Countries citing papers authored by H Lambert

Since Specialization
Citations

This map shows the geographic impact of H Lambert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Lambert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Lambert more than expected).

Fields of papers citing papers by H Lambert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H Lambert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Lambert. The network helps show where H Lambert may publish in the future.

Co-authorship network of co-authors of H Lambert

This figure shows the co-authorship network connecting the top 25 collaborators of H Lambert. A scholar is included among the top collaborators of H Lambert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Lambert. H Lambert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Epenetos, Agamemnon A., et al.. (2000). Long term survival of patients with advanced ovarian cancer treated with intraperitoneal radioimmunotherapy. International Journal of Gynecological Cancer. 10(s1). 44–46. 69 indexed citations
2.
Rustin, Gordon, Ann E. Nelstrop, Michael Crawford, et al.. (1997). Phase II trial of oral altretamine for relapsed ovarian carcinoma: evaluation of defining response by serum CA125.. Journal of Clinical Oncology. 15(1). 172–176. 58 indexed citations
3.
Rustin, G.J.S., Ann E. Nelstrop, M F Brady, et al.. (1996). Defining response of ovarian carcinoma to initial chemotherapy according to serum CA 125.. Journal of Clinical Oncology. 14(5). 1545–1551. 312 indexed citations
4.
Harrington, Kevin J., Mark Harrison, Katherine J. Evans, et al.. (1996). Surgical clips in planning the electron boost in breast cancer: A qualitative and quantitative evaluation. International Journal of Radiation Oncology*Biology*Physics. 34(3). 579–584. 103 indexed citations
5.
Harrington, Kevin J. & H Lambert. (1995). The search for optimal chemotherapy for advanced epithelial ovarian cancer. Clinical Oncology. 7(6). 359–365. 1 indexed citations
6.
Harrington, Kevin J. & H Lambert. (1994). Current issues in the non-surgical management of primary vulvar squamous cell carcinoma. Clinical Oncology. 6(5). 331–336. 1 indexed citations
7.
Thomas, H. & H Lambert. (1992). Solitary cerebral metastases from gynaecological malignancy: The case for radical therapy. Clinical Oncology. 4(2). 133–134. 4 indexed citations
8.
Rustin, Gordon, et al.. (1991). A Phase II study of ondansetron as antiemetic prophylaxis in patients receiving carboplatin for advanced ovarian cancer. Annals of Oncology. 2(8). 607–608. 6 indexed citations
9.
Stewart, John S., V Hird, D Snook, et al.. (1990). Intraperitoneal yttrium-90-labeled monoclonal antibody in ovarian cancer.. Journal of Clinical Oncology. 8(12). 1941–1950. 102 indexed citations
10.
Rustin, Gordon, et al.. (1989). Use of CA-125 to predict survival of patients with ovarian carcinoma. North Thames Cooperative Group.. Journal of Clinical Oncology. 7(11). 1667–1671. 69 indexed citations
11.
Epenetos, A. A., Alastair J. Munro, Simon Stewart, et al.. (1987). Antibody-guided irradiation of advanced ovarian cancer with intraperitoneally administered radiolabeled monoclonal antibodies.. Journal of Clinical Oncology. 5(12). 1890–1899. 159 indexed citations
12.
Bracard, Serge, et al.. (1986). Computerized tomography and MRI in Marchiafava-Bignami disease.. PubMed. 13(2). 87–94. 18 indexed citations
13.
Rampling, R & H Lambert. (1985). Multiple Basal Cell Carcinomas in two cases of ankylosing spondylitis treated with X-ray therapy. British Journal of Radiology. 58(686). 178–181. 6 indexed citations
14.
Lambert, H & R. J. Berry. (1985). High dose cisplatin compared with high dose cyclophosphamide in the management of advanced epithelial ovarian cancer. BMJ. 290(6478). 1351.3–1351. 1 indexed citations
16.
Lambert, H. (1981). TREATMENT OF EPITHELIAL OVARIAN CANCER. BJOG An International Journal of Obstetrics & Gynaecology. 88(12). 1169–1173. 1 indexed citations
17.
Larcan, A, et al.. (1979). Acute intoxication by phenformine hyperlactatemia reversible with extra-renal purification.. PubMed. 21 Suppl. 19–22. 2 indexed citations
18.
Lambert, H, et al.. (1979). The treatment of carcinoma of the cervix and endometrium using the cathetron at the Middlesex hospital. Clinical Radiology. 30(3). 253–258. 6 indexed citations
19.
Larcan, A, et al.. (1974). [Intoxication by ingestion of a massive dose of carbon tetrachloride. Recovery in probable relation to early hyperbaric oxygen therapy].. PubMed. 6(6). 286–9. 5 indexed citations
20.
Walford, J., Jane Cooper, R. S. F. Schilling, et al.. (1968). Comparison of Side-effects of Tetracycline and Tetracycline Plus Nystatin. BMJ. 4(5628). 411–415. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026